まとめ
結血因子II,V,VIIIは,股関節置換手術中に手術された足で有意に高かった. 手術された足の血の蓄積を減らすことは,深静脈血栓症を予防するのに役立ちます.
科学分野:
- 整形外科 整形外科
- 血液学 ヘマトロジ
- 血管医学 血管医学とは
背景:
- 股関節関節炎は,外科的介入を必要とする一般的な状態です.
- 全身の股関節置換手術は,深静脈血栓症 (DVT) などのリスクが伴う主要な整形外科手術です.
- 手術中の局所的静脈静止変化を理解することは,DVT予防戦略にとって極めて重要です.
研究 の 目的:
- トータルヒップ置換手術中の全身循環と比較して,手術された肢体における特定の凝固因子の濃度を調査する.
- 局所的な凝固因子の増加が,DVTのリスクと相関するかどうかを判断する.
主な方法:
- 17人の患者から血液サンプルを採取した.
- 凝固因子II,V,VIIIは,手術を受けた肢体と全身循環からの血液で測定されました.
- 2つのサイト間の因子濃度を比較するために統計分析が行われました.
主要な成果:
- 凝固因子II,V,VIIIの濃度は,手術を受けた肢体において一貫して,そして有意に高かった.
- この局所的な上昇は,手術現場の血管系内で凝固の可能性が増加していることを示唆しています.
- この発見は,手術された肢体における血栓形成に寄与する潜在的なメカニズムを示唆している.
結論:
- 股関節置換手術中に手術された肢体の凝固因子のレベルが上昇すると,DVTのリスクが増加する可能性があります.
- 手術された足の静脈静止 (血液の集積) を減らすための施策を実施することは,DVTの予防のための実行可能な戦略である可能性があります.
- 整形外科の処置中の局所的静脈調節に関するさらなる研究が必要である.
関連する概念動画
Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...


